- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07950696
Cognitive Function in Athletes Cleared for Return-to-Play After Sport-Related Concussion (Cog-RTP)
Cognitive Function in Athletes Cleared for Return-to-Play After Sport-Related Concussion (Cog-RTP)
The purpose of this study is to determine whether a brief, objective cognitive assessment can detect exercise-induced changes in cognitive performance in adolescent athletes who have been medically cleared for return-to-play following sport-related concussion.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Kayla Covert, DPT
- Phone Number: 2146031527
- Email: Kayla.Covert@BSWHealth.org
Study Locations
-
-
Texas
-
Frisco, Texas, United States, 75034
- Baylor Scott & White Sports Therapy & Research at the Star
-
Contact:
- Kayla Covert, DPT
- Email: Kayla.Covert@BSWHealth.org
-
Principal Investigator:
- Kayla Covert, DPT
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 12-18 years old
- Actively engaged in organized sports activities within the past 12 months
- Completed RTP (Return-to-Play) testing within the past 30 days
Exclusion Criteria:
- History of ocular or muscular spasms
- History of epileptic seizures
- History of fainting or loss of consciousness triggered by flashes of light, patterns, or exposure to infrared light sources (e.g., eye tracker)
- History of eye surgery and lenses implanted with different prescriptions in each eye
- History of ptosis (drooping eyelids)
- Taking medications that cause pupil dilation
- Active concussion symptoms
- Cardiovascular, respiratory, or neurological conditions contraindicating exertion
- Orthopedic or neurologic, or other limitations
- History of moderate or severe traumatic brain injury (GCS ≤12)
- Uncontrolled asthma
- Limited English proficiency
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Adolescents following medical clearance from concussion
|
Participants will undergo a supervised, 30-minute, moderate-intensity, bodyweight workout with a warm-up and a cool down. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cognitive performance
Time Frame: Baseline (pre-exercise) and immediately post-exercise during the single study visit
|
Cognitive performance measured before and immediately after standardized exercise during a single study visit. Cognitive domains assessed include Processing Speed, Executive Function, Working Memory, Short-Term Memory, Sustained Attention, Selective Attention, and Spatial Perception. |
Baseline (pre-exercise) and immediately post-exercise during the single study visit
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rivermead Post Concussion Questionnaire 3 (RPQ-3)
Time Frame: baseline, pre-intervention
|
The RPQ-3 assesses the severity of three post-concussion symptoms: headache, dizziness, and nausea. Each item is scored on a scale of 0-4, with a total score ranging from 0 to 12. Higher scores indicate greater post-concussion symptom severity (worse outcomes). |
baseline, pre-intervention
|
|
Pediatric Quality of Life Inventory Short Form 15 (PedsQL 4.0 SF-15)
Time Frame: baseline, pre-intervention
|
The PedsQL 4.0 SF-15 assesses health-related quality of life in children and adolescents across four domains: physical functioning, emotional functioning, social functioning, and school functioning. The 15 items are rated on a 5-point Likert scale (0-4) and reverse-scored and linearly transformed to a 0-100 scale. The total score ranges from 0 to 100, with higher scores indicating better health-related quality of life (better outcomes). |
baseline, pre-intervention
|
|
Brief Pittsburgh Sleep Quality Index (B-PSQI)
Time Frame: baseline, pre-intervention
|
The B-PSQI assesses sleep quality over the past month across seven domains: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medication, and daytime dysfunction. The six items are scored on a scale of 0-3, with a total score ranging from 0 to 18. Higher scores indicate poorer sleep quality (worse outcomes). |
baseline, pre-intervention
|
|
Vestibular/Oculomotor Motor Screening (VOMS)
Time Frame: baseline, pre-intervention
|
The VOMS assesses vestibular and ocular motor symptom provocation following concussion. The assessment includes smooth pursuits, horizontal and vertical saccades, near point of convergence, vestibulo-ocular reflex (VOR), and visual motion sensitivity (VMS). Participants rate four symptoms (headache, dizziness, nausea, and fogginess) on a scale of 0-10 before and immediately after each task. The total symptom score ranges from 0 to 280, with higher scores indicating greater symptom severity (worse outcomes). Symptom provocation is also assessed by calculating the change in symptom ratings from baseline. |
baseline, pre-intervention
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Brain Injuries, Traumatic
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Wounds and Injuries
- Craniocerebral Trauma
- Trauma, Nervous System
- Head Injuries, Closed
- Wounds, Nonpenetrating
- Brain Injuries
- Brain Concussion
- Motor Activity
- Movement
- Musculoskeletal Physiological Phenomena
- Musculoskeletal and Neural Physiological Phenomena
- Exercise
Other Study ID Numbers
- 026-373
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Aggregated and anonymized study findings will be reported in scientific publications. De-identified data will be shared with collaborators as specified in data use agreements after institutional review and approval.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.